We have previously shown that reduced SIRPγ expression potentiates effector responses from human T-cells [8], suggesting that perturbed SIRPγ expression on T-cells may play a critical role in immune dysregulation of autoimmune diseases. Here, SIRPG is linked to autoimmune disease.